SCOPUS 정보 검색 플랫폼

International Journal of Clinical Practice, Supplement

Volumn , Issue 93, 1998, Pages 9-13

Global trends in the health-care environment: Economic considerations in making a case for people with amyotrophic lateral sclerosis

(1) Bloor, Karen a

a UNIVERSITY OF YORK (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CONFERENCE PAPER; DRUG COST; ECONOMIC EVALUATION; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH ECONOMICS; MEDICAL ETHICS; PRIORITY JOURNAL; RESOURCE ALLOCATION; ARTICLE; HEALTH CARE COST; HEALTH CARE PLANNING; HUMAN;

AMYOTROPHIC LATERAL SCLEROSIS; DRUG COSTS; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS;

EID: 0031595489 PISSN: 1368504X EISSN: None Source Type: Journal
DOI: None Document Type: Conference Paper

Times cited : (1)

References (12)

1
- 79956009358
- Letter
- Loewy E. Letter. N Engl J Med 1980; 302: 12.
- (1980) N Engl J Med , vol.302 , pp. 12
- Loewy, E.¹

2
- 0004264802
- London: Nuffield Provincial Hospitals Trust
- Cochrane AL. Effectiveness and Efficiency. London: Nuffield Provincial Hospitals Trust, 1972.
- (1972) Effectiveness and Efficiency
- Cochrane, A.L.¹

3
- 0004036934
- New York: Basic Books
- Fuchs V. Who shall live? New York: Basic Books, 1974.
- (1974) Who Shall Live?
- Fuchs, V.¹

4
- 0027328246
- Health-care reform: The global search for Utopia
- Klein R. Health-care reform: the global search for Utopia. Br Med J 1993; 307: 752.
- (1993) Br Med J , vol.307 , pp. 752
- Klein, R.¹

5
- 0007691520
- Toronto: Ontario Ministry of Health
- Ontario Ministry of Health. Guidelines for Preparation of Economic Analysis in Submission to Drug Programs Branch for Listing in the Ontario Benefit Formulary/Comparative Drug Index. Toronto: Ontario Ministry of Health, 1991.
- (1991) Guidelines for Preparation of Economic Analysis in Submission to Drug Programs Branch for Listing in the Ontario Benefit Formulary/Comparative Drug Index

6
- 7144251247
- Ottowa: CCOHTA
- Canadian Co-ordinating Office for Health Technology Assessment. Guidelines for Economic Evaluation of Pharmaceuticals: Canada. Ottowa: CCOHTA, 1992.
- (1992) Guidelines for Economic Evaluation of Pharmaceuticals: Canada

7
- 7144257929
- FDA vulnerable on cost-effectiveness rules?
- FDA vulnerable on cost-effectiveness rules? Scrip. 1994; 1986/87: 22.
- (1994) Scrip , vol.1986 , Issue.87 , pp. 22

8
- 7144222813
- PhRMA's pharmacoeconomic guidelines
- PhRMA's pharmacoeconomic guidelines. Scrip 1995; 2016: 2023.
- (1995) Scrip , vol.2016 , pp. 2023

9
- 0003866632
- Department of Health Press Release 94/251
- Department of Health. Guidelines for the economic evaluation of pharmaceuticals. Department of Health Press Release 94/251; 1994.
- (1994) Guidelines for the Economic Evaluation of Pharmaceuticals

10
- 0029824601
- A purchaser experience of managing new expensive drugs: Interferon beta
- Rous E, Coppel A, Haworth J, Noyce S. A purchaser experience of managing new expensive drugs: Interferon beta. Br Med J 1996; 313: 1195-1196.
- (1996) Br Med J , vol.313 , pp. 1195-1196
- Rous, E.¹ Coppel, A.² Haworth, J.³ Noyce, S.⁴

11
- 0029801305
- Interferon beta in multiple sclerosis
- Richards RG. Interferon beta in multiple sclerosis. Br Med J 1996; 313: 1159.
- (1996) Br Med J , vol.313 , pp. 1159
- Richards, R.G.¹

12
- 0003487766
- London: HMSO
- Summerfield AQ, Marshall D. Cochlear Implantation in the UK 1990-1994. London: HMSO, 1995.
- (1995) Cochlear Implantation in the UK 1990-1994
- Summerfield, A.Q.¹ Marshall, D.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.